A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

Elliot Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock-Guttman, Jacqueline E. Durfee, Amy Conger, Ellen Carl, Olaf Stuve, Benjamin Greenberg, Amber Salter, Teresa C. Frohman, Anjali Shah, Angela Bates, Jennifer L. Cox, Michael G. Dwyer, Anjali Shah, Benjamin M. Greenberg, Michael K. RackeRobert Zivadinov

Research output: Contribution to journalArticle

26 Scopus citations

Fingerprint Dive into the research topics of 'A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences